Figure 4
Figure 4. Aberrations of the p19Arf-Mdm2-p53 pathway in Slp65-deficient leukemias. (A) Western blot analysis of total cell lysates from pre-B cell tumors from Slp65−/− mice for the expression of p53, p19Arf, Mdm2, and Syk (loading control). (B) Quantitative RT-PCR analyses of p21Cip1 expression in Slp65−/− pre-B cell tumors without or with detectable p53 protein, normalized to GAPDH. Values in sorted WT BM B220+ cells were set to 1. Horizontal lines represent mean values of the relative expression levels. (C) Western blot analysis of total cell lysates from pre-B cell tumors from Btk−/−Slp65−/− mice for the expression of p53, p19Arf, Mdm2, and Syk (loading control). (D) Western blot analysis of total cell lysates from pre-B cell tumors from p53−/−Slp65−/− mice for the expression of p19Arf, Mdm2, and Syk (loading control). Protein of p53 was not detected in p53−/−Slp65−/− tumors.

Aberrations of the p19Arf-Mdm2-p53 pathway in Slp65-deficient leukemias. (A) Western blot analysis of total cell lysates from pre-B cell tumors from Slp65−/− mice for the expression of p53, p19Arf, Mdm2, and Syk (loading control). (B) Quantitative RT-PCR analyses of p21Cip1 expression in Slp65−/− pre-B cell tumors without or with detectable p53 protein, normalized to GAPDH. Values in sorted WT BM B220+ cells were set to 1. Horizontal lines represent mean values of the relative expression levels. (C) Western blot analysis of total cell lysates from pre-B cell tumors from Btk−/−Slp65−/− mice for the expression of p53, p19Arf, Mdm2, and Syk (loading control). (D) Western blot analysis of total cell lysates from pre-B cell tumors from p53−/−Slp65−/− mice for the expression of p19Arf, Mdm2, and Syk (loading control). Protein of p53 was not detected in p53−/−Slp65−/− tumors.

Close Modal

or Create an Account

Close Modal
Close Modal